Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AES Corp (AES) vs Nuwellis Inc (NUWE) Price & Performance

Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

AES Corp vs Nuwellis Inc — how do they compare? AES Corp trades at $14.72 (market cap $10.49B), while Nuwellis Inc trades at $1.48 (market cap $542.80K). The key difference: AES Corp is far larger — about 19325.7× Nuwellis Inc's market cap, and AES Corp pays a 4.79% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

AESNUWE
Market Cap
$10.49B$542.80K
Sector
UtilitiesTechnology
52-Week High
$17.28$220.50
52-Week Low
$12.51$1.42
Enterprise Value
$40.75B-$1.27M
Dividend Yield
4.79%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AES Corp

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.

The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.

Returns comparison

Trailing returns across standard periods

About AES Corp

AES is a global power company operating across 14 countries and 4 continents. Its current generation portfolio as of year-end 2021 consists of over 31 gigawatts of generation, with the generation mix composed of renewables (43%), gas (32%), coal (23%), and oil (2%). The company has 3.5 gigawatts of generation under construction. AES has majority ownership and operates six electric utilities distributing power to 2.6 million customers.

Read more on AES

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE